Clinical Trial Update: To Determine the Safety, Tolerability, Pharmacokinetics and Effect on Pain of a Single Intra-articular Administration of Canakinumab in Patients With Osteoarthritis in the Knee [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety, tolerability, pharmacokinetics, and effect on pain of a single intra-articular dose of canakinumab in knee osteoarthritis; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• Canakinumab (canakinumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Osteoarthritis | Phase 2 | Status: COMPLETED | Results posted: 2012-08-30